Arcus Calls Quits On Anti-TIGIT Candidate After Phase III Termination

 
• By Joseph Haas
  
Arcus Biosciences
Arcus is giving up on the anti-TIGIT mechanism in IO • Source: Shutterstock

More from Strategy

More from Business